Preliminary experiments show conolidine may well inhibit specific ion channels, lowering neuronal excitability and restricting ache signals. This system is especially relevant in neuropathic agony, where abnormal signaling triggers persistent distress. Additionally, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to d